Outsourcing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

As specialty API outsourcing grows, manufacturers and contract development and manufacturing organizations are investing for the long haul.

Specialty Markets and Services Drive API Growth

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Sustainable harvesting combined with CMO expertise helped Centroflora CMS ensure supply continuity after it acquired Boehringer Ingelheim's non-captive API phytochemicals portfolio.

Success Story: Transferring a Phytochemical API Portfolio

Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.

FDA Approves Ash Stevens as API Manufacturer for Takeda’s Multiple Myeloma Drug

Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.

Catalent Reports Action to Restart Softgel Facility

Companies in the US will now have the opportunity to tap into Hermes Pharma’s technical expertise in effervescent and chewable tablets, instant drinks, lozenges, and orally disintegrating granules (ODGs).

Hermes Pharma Expands Formulation Services to US Market

Ignoring a contract partner’s ability to handle highly potent APIs (HPAPIs) safely may have serious consequences. Drug owners and contract service providers alike must understand the complexities and liabilities involved in working with HPAPIs.

Handling HPAPIs: Do Your CMOs Have the Right Stuff?

Hovione will use Merrion's GIPET absorption-enhancing technology for solid-dosage drugs.

Hovione Partners with Merrion Pharmaceuticals on Absorption-Enhancing Technology

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.

Gaining Insights on Contract Chemical API Manufacturing An Industry Roundtable

External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ingredients and intermediates.

A Shifting Landscape for the Global API Market

Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.

Contract Manufacturing, Chemical-based Drug Production